| Tap a line for its trend | Last 12Mto Jun 2026 | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 132.27× | 132.27× | 191.80× | 162.71× | 170.85× | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 11.18× | 11.73× | 2.59× | 2.10× | 7.49× | ||
| 1.06× | 1.06× | 0.60× | 0.44× | 0.29× | ||
| 1.47× | 1.47× | −0.30× | −1.37× | 0.51× | ||
| 4.55× | 4.55× | −0.34× | −1.36× | 0.96× |
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
Ratios — % unless marked × 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Last 12M 30/06/2026 | |
|---|---|---|---|---|---|---|
| Receivable Days (DSO) | 170.85 | 162.71 | 191.80 | 132.27 | 132.27 | |
| Working Capital Turnover | 7.49 | 2.10 | 2.59 | 11.73 | 11.18 | |
| Asset Turnover | 0.29 | 0.44 | 0.60 | 1.06 | 1.06 | |
| Cash Conversion (CFO/Net Income) | 0.51 | -1.37 | -0.30 | 1.47 | 1.47 | |
| CFO/EBITDA | 0.96 | -1.36 | -0.34 | 4.55 | 4.55 |